Esophageal Cancer in Northeastern Iran
NCT00450788 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50045
Last updated 2026-04-06
Summary
Background:
-Esophageal cancer is the most common cancer in Iran s Golestan Province. Nutritional deficiencies, ethnicity and environmental exposures might contribute to the development of this disease.
Objectives:
-To better understand the cause of esophageal cancer in Golestan Province and to reduce its occurrence there.
Eligibility:
-Adults from the Gonbad, Aq-Qala and Kalaleh districts of eastern Golestan Province in Iran.
Design:
* The study is a collaboration between NIH, the Digestive Disease Research Center of Teheran University of Medical Sciences, and the International Agency for Research on Cancer.
* Participants complete a lifestyle questionnaire and food frequency questionnaire.
* Samples of participants blood, urine, hair and toenail clippings are obtained.
Conditions
- Esophageal Cancer
- GI Disease
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Christian C Abnet, Ph.D. · National Cancer Institute (NCI)
Eligibility
- Min Age
- 30 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-03-15
Countries
- Iran
Study Locations
More Related Trials
-
Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus
NCT00003321 ·Status: COMPLETED
-
Esophageal Cancer Risk Registry
NCT00260585 ·Status: RECRUITING
-
NCI UNC Project ESCC
NCT03206125 ·Status: TERMINATED
-
Prediction Model of Response for CCRT in Esophageal Cancer
NCT03081988 ·Status: RECRUITING
-
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
NCT06960889 ·Status: ACTIVE_NOT_RECRUITING
-
Esophageal Cancer Genetics Studies
NCT00341276 ·Status: COMPLETED
-
Quality Of Life Outcomes Following Treatment for Esophageal Cancer
NCT00598117 ·Status: COMPLETED
-
Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.
NCT06020885 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1
NCT04455282 ·Status: RECRUITING
-
Genome-wide Association Study
NCT01498757 ·Status: WITHDRAWN
-
Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer
NCT01858805 ·Status: COMPLETED
-
Detection of (Sub)Clinical Toxicity in Irradiated vs. Non-irradiated Surgically Treated Esophageal Cancer Patients: a Pilot Study (CROSS SECT)
NCT03396614 ·Status: COMPLETED
-
Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer
NCT00629863 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography in Determining Stage of Esophageal Cancer
NCT00004867 ·Status: COMPLETED ·Phase: NA
-
Discovering Patterns in Experiences of Patients in Esophageal Cancer Clinical Research
NCT05831150 ·Status: NOT_YET_RECRUITING
-
Treatment Outcomes of Esophageal Cancer
NCT05177393 ·Status: RECRUITING
-
Improve the Treatment of Thoracic Esophageal Cancer
NCT01137123 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)
NCT01688908 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer
NCT01558648 ·Status: COMPLETED
-
Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.
NCT00193882 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]
NCT00003381 ·Status: TERMINATED
-
A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer
NCT01391572 ·Status: UNKNOWN ·Phase: PHASE2
-
Early Detection of Esophageal Cancer
NCT00341523 ·Status: TERMINATED
-
Role of Esophagectomy in Complete Responders to CCRT
NCT01740375 ·Status: TERMINATED ·Phase: PHASE3
-
Retrospective Review of Esophageal Cancer at MSKCC
NCT05706558 ·Status: RECRUITING